Aspartame Safety: Cancer Risk, Side Effects and What IARC Actually Said

Short answer: Aspartame remains approved for use within established intake limits. In 2023, the International Agency for Research on Cancer (IARC) classified it as “possibly carcinogenic to humans” (Group 2B) because the evidence for cancer in humans was limited. At the same time, the WHO/FAO Joint Expert Committee on Food Additives (JECFA) reviewed the risk data and kept its acceptable daily intake at 40 mg/kg of body weight per day. The U.S. FDA uses an ADI of 50 mg/kg/day.

Those statements are not contradictory. IARC asks whether an agent can cause cancer under some circumstances. JECFA and FDA ask how much exposure is considered acceptable in ordinary use.

What is aspartame?

Aspartame is a low-calorie sweetener roughly 200 times sweeter than sucrose. It is used in many diet drinks, sugar-free foods, chewing gum and tabletop sweeteners.

After digestion, aspartame is broken down into phenylalanine, aspartic acid and methanol. These compounds also occur through ordinary foods and metabolism; the safety question depends on dose and individual susceptibility rather than on the fact that these metabolites exist.

Why did IARC classify aspartame as “possibly carcinogenic”?

In July 2023, IARC classified aspartame as Group 2B, “possibly carcinogenic to humans.” The agency described the evidence for carcinogenicity in humans as limited.

This classification is often misunderstood. IARC hazard groups do not tell you how large the risk is at normal dietary exposure. They identify whether a hazard is plausible based on the available evidence.

A Group 2B classification therefore does not mean that normal aspartame consumption has been shown to cause cancer. It means the evidence was sufficient to raise a possibility but not strong enough to establish causation in humans.

IARC summary of the 2023 evaluation.

What did JECFA conclude at the same time?

JECFA performed a separate risk assessment, examining toxicology, epidemiology and estimated dietary exposure. It did not find sufficient reason to change the existing acceptable daily intake and retained an ADI of 0–40 mg/kg body weight per day.

For an 80 kg adult, that corresponds to 3,200 mg per day as the JECFA upper acceptable daily intake. This is not a recommended target. An ADI is a conservative exposure level intended to be acceptable every day over a lifetime.

WHO/JECFA 2023 technical report.

What does the FDA say?

The U.S. FDA continues to state that the available evidence supports the safety of aspartame for the general population under approved conditions of use. Its ADI is 50 mg/kg/day.

The difference between 40 mg/kg in JECFA/Europe and 50 mg/kg in the United States does not mean one authority considers aspartame dangerous and the other does not. They use somewhat different regulatory frameworks and safety assessments.

FDA: Aspartame and Other Sweeteners in Food.

Who really does need to avoid aspartame?

The clearest exception is people with phenylketonuria (PKU), a rare inherited disorder that prevents normal metabolism of phenylalanine. Because aspartame provides phenylalanine, people with PKU need to restrict or avoid it according to their medical dietary plan.

This is why products containing aspartame carry a phenylalanine warning in many countries.

Does aspartame cause headaches, dizziness or mood changes?

People do report headaches and other symptoms that they attribute to aspartame. That experience should not simply be dismissed. But self-reported temporal association is different from proving a reproducible pharmacological effect.

Controlled challenge studies have not established a consistent syndrome of headache, dizziness, depression or gastrointestinal symptoms in the general population at ordinary exposure levels. Some individuals may nevertheless notice symptoms after particular products and can reasonably choose to avoid them.

The older version of this article listed a broad range of symptoms as if they were established aspartame side effects. The evidence does not support that level of certainty.

Is “aspartame allergy” a real diagnosis?

A true IgE-mediated allergy to aspartame has not been established as a common clinical condition. Case reports and symptom reports exist, but hives, swelling or breathing difficulty after a food or drink can also be caused by other ingredients.

Anyone with acute facial swelling, wheezing or difficulty breathing should treat that as a medical emergency regardless of the suspected ingredient.

Does aspartame cause weight gain?

Aspartame itself contributes very little energy at the amounts used for sweetening. Replacing a sugar-sweetened beverage with a zero-calorie version can therefore reduce calorie and sugar intake.

The harder question is whether habitual use of non-sugar sweeteners improves long-term weight and metabolic outcomes. Randomized trials and observational studies do not always point in the same direction, partly because people at higher risk of obesity or diabetes may be more likely to choose diet products in the first place.

So “aspartame causes obesity” is too strong, but “diet drinks automatically produce weight loss” is also too strong. Their effect depends mainly on what they replace and on the rest of the diet.

Sugar or aspartame: which is better?

There is no universal answer, but the comparison is easier if the goal is clear.

If a person drinks several sugar-sweetened beverages each day, replacing them with an aspartame-sweetened version can substantially reduce added sugar and calories and does not raise blood glucose in the way the sugar-containing drink does.

If someone rarely consumes sweetened drinks at all, there is no health requirement to start consuming artificial sweeteners. Water, coffee, tea and other unsweetened drinks remain simple options.

Aspartame should therefore be viewed primarily as a sugar-replacement tool, not as a health supplement.

Aspartame vs stevia

Steviol glycosides and aspartame are chemically different sweeteners, but “natural” versus “artificial” is not a useful safety test by itself. Both are intensely sweet compounds used in small amounts and both have regulatory safety assessments and acceptable-use limits.

Choice can reasonably come down to taste, gastrointestinal tolerance, product formulation, cost and personal preference rather than an assumption that plant-derived automatically means safer.

How worried should you be about the IARC classification?

The appropriate response is neither panic nor dismissal.

The 2023 IARC evaluation identified a possible carcinogenic hazard based on limited evidence. That is a legitimate scientific signal worth continued study. But the parallel JECFA risk assessment did not find evidence requiring a reduction of the existing 40 mg/kg/day ADI, and FDA continues to consider approved uses safe within its exposure limits.

If future high-quality studies demonstrate a clearer dose-response relationship or stronger causal evidence, recommendations should change. At present, the evidence does not support telling the general population that normal aspartame exposure has been proven to cause cancer.

Bottom line

Cancer: IARC classifies aspartame as “possibly carcinogenic” based on limited evidence, not as a proven human carcinogen.

Exposure limits: JECFA retains an ADI of 40 mg/kg/day; FDA uses 50 mg/kg/day.

PKU: People with phenylketonuria need to restrict or avoid aspartame because it contains phenylalanine.

Other symptoms: Headaches and other symptoms are reported by some individuals, but a broad reproducible “aspartame side-effect syndrome” has not been established in controlled evidence.

Practical use: Aspartame can reduce sugar and calorie intake when it replaces sugar-sweetened products, but it is not necessary for health and it should not be treated as a weight-loss drug.

Sources

1. IARC. Aspartame hazard and risk assessment results released. 2023.

2. WHO/FAO JECFA. Evaluation of certain food additives: ninety-sixth report. 2023.

3. U.S. FDA. Aspartame and Other Sweeteners in Food.